Gowan acquires all shares of Isagro

Gowan Company is pleased to announce that it has entered into a binding agreement to purchase all shares of Piemme S.r.l from Giorgio Basile and the other shareholders. Piemme S.r.l is the controlling shareholder of Isagro S.p.A., and the transaction announced today is the first step in the purchase by Gowan Company of all shares of Isagro S.p.A.

Isagro is the owner of important active ingredients, including copper hydroxide/oxychloride, tetraconazole and kiralaxyl globally, and is known for its research and development efforts in the crop protection and biopesticide industries.

Gowan, headquartered in Yuma, Arizona, operates in the agricultural solutions business and is specialized in developing, marketing, and processing agricultural inputs such as crop protection products, seeds, and fertilizers.

Juli Jessen, Chief Executive Officer of Gowan Group, said: “As a partner since 2013, Isagro has repeatedly impressed us. We look forward to expanding commercial opportunities, especially integrating the manufacturing and science depth at Isagro Group’s facilities. These additional competencies are instrumental in positioning Gowan as global agricultural practices evolve”.

Giorgio Basile, Chairman of Isagro, said: “The Transaction with Gowan will allow to value at their best the tangible and intangible assets developed by Isagro since its origins. The complementarity between Gowan and Isagro ensures the continuity of Isagro’s mission in the agro-pharmaceutical sector.”

At the closing of its purchase of Piemme, Gowan will launch a mandatory tender offer (MTO), to purchase all outstanding shares of Isagro.

For more information:
370 South Main Street
Yuma, Arizona 85364
(800) 883-1844

Isagro USA
430 Davis Drive, Suite 240
Morrisville, NC 27560, US

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Facebook Twitter Rss LinkedIn

© HortiDaily.com 2021

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber